Use of oesophageal stress response proteins as potential... : European Journal of Gastroenterology & Hepatology (original) (raw)

Original Articles: Oesophageal and Gastric Disorders

Use of oesophageal stress response proteins as potential biomarkers in the screening for Barrett's oesophagus

Groome, Maximillian; Lindsay, Jamie; Ross, Peter E.; Cotton, James P.; Hupp, Ted R.; Dillon, John F.

Gut Group, Ninewells Hospital and Medical School, University of Dundee, Scotland, UK

Correspondence to Dr Max Groome, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland DD1 9SY, UK

Tel: +44 138 266 0111; e-mail: [email protected]

Received 24 September 2007 Accepted 4 March 2008

Abstract

Introduction

Oesophageal adenocarcinoma is an increasingly common diagnosis and cause of death; risk factors include ‘Barrett's epithelium’ (BE). Endoscopic surveillance is most commonly used but is expensive. Other methods of surveillance have been suggested including nonendoscopic balloon cytology, but are handicapped by relying on cytological techniques; hence the need for a partner technology such as a biomarker. From earlier work we know the most commonly expressed oesophageal stress response proteins are SEP 53, SEP70 and anterior gradient-2 (AG-2). We set out to map the expression of these stress response proteins and explore their potential as prototype biomarkers of BE.

Methods

Patients (_n_=192) presenting to the endoscopy unit of a large teaching hospital with symptoms of gastro-oesophageal reflux disease or a known BE were recruited, endoscopically examined and the biopsies obtained were examined for heat shock protein expression.

Results and discussion

Normal controls and those with oesophagitis predominantly expressed SEP 53 (76.9/91.95%) and SEP 70 (79.48/89.65%). Although those with BE expressed AG-2; using this expression as a marker for BE, gives a sensitivity of 65.15% and specificity of 89.68% (positive predictive value of 76.78% and negative predictive value of 84.9%) and in gastro-oesophageal reflux disease a sensitivity of 65.15% and specificity of 90.80% (positive predictive value of 84.31% and negative predictive value of 77.45%). We confirmed that AG-2 is preferentially expressed in BE; suggesting its use would allow a screening tool with specificity of around 90%.